Effercal D3

Quick links to important sections

Effercal D3

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Effercal D3

Property Description
Active ingredients Calcium Carbonate, Colecalciferol (Vitamin D3)
Form Effervescent Tablet
Pharmacological class Mineral Supplement and Vitamin D Analogue
Common use Maintaining Mineral Homeostasis
Origin Semi-synthetic Combination Product

Defining Effercal D3: Classification and Core Components

Effercal D3 is an oral fixed-dose combination preparation classified as both a Mineral Supplement and a Vitamin D Analogue, specifically formulated to provide two essential micronutrients concurrently. The preparation combines the mineral Calcium, supplied as Calcium Carbonate, with the fat-soluble vitamin Colecalciferol (Vitamin D3). The need for the combined formulation is supported by pharmacological studies, which confirm Colecalciferol's role as the physiologically preferred form of Vitamin D for sustaining long-term levels in the body.


The Physical Form and Composition of Effercal D3

The standard presentation of Effercal D3 is the Effervescent Tablet, an Oral Preparation that must be fully dissolved in water prior to ingestion. This dosage form ensures the rapid and complete dispersion of the active ingredientsCalcium Carbonate and Colecalciferol—a characteristic that distinguishes it from conventional solid pills. The effervescent mechanism facilitates immediate availability of the calcium, which is essential for numerous biological processes, including skeletal strength and nerve signaling.


General Purpose: Why is the Calcium and Vitamin D3 Combination Necessary?

The general purpose of Effercal D3 is to support mineral homeostasis by ensuring an efficient supply and utilization of calcium within the body. The rationale for this fixed-dose combination is rooted in the high-level biological mechanism where Colecalciferol fundamentally enhances the efficiency of Calcium absorption from the gastrointestinal tract. By supplying both the mineral and its essential regulatory factor, the preparation's overarching aim is to contribute to skeletal strength and the vital process of bone calcification.

Regulatory References

  1. Calcium and bones - MedlinePlus

What side effects are possible with Effercal D3?

Possible Side Effects and Safety Information

The safety profile of Effercal D3 (Calcium Carbonate and Colecalciferol) is characterized by the potential for mineral accumulation, which determines the most significant documented adverse effects and necessary safety precautions. Adverse reactions are grouped and classified by frequency and affected organ system in official regulatory documents.


Official Adverse Reactions and Frequencies

Classification Frequency Examples of Adverse Reactions
Metabolism Disorders Uncommon Hypercalcaemia (high blood calcium levels), Hypercalciuria (high urinary calcium levels)
Gastrointestinal Disorders Common/Expected Constipation, flatulence, nausea, gastric pain
Skin Disorders Rare Pruritus (itching), rash, urticaria (hives)

Serious Adverse Reactions and Key Safety Constraints

The most important safety concern is the risk of Hypercalcaemia, which, in cases of chronic excessive intake, is associated with the rare but serious risks of Milk-Alkali Syndrome and soft tissue/vascular calcification.

Regulatory documents list several conditions where the product is contraindicated (prohibited for use). These include pre-existing Hypercalcaemia, Hypercalciuria, Nephrolithiasis (kidney stones), Nephrocalcinosis, and Hypervitaminosis D (excessive Vitamin D levels).

Population-Specific Safety Notes

Official labels require increased caution and monitoring of serum calcium and renal function in specific patient populations, particularly older adults and those with impaired renal function, especially during long-term treatment. Furthermore, caution is advised for patients with sarcoidosis or immobilized osteoporosis due to an elevated risk of hypercalcaemia.

Overdose and Emergency Response

Overdose and When to Seek Help

The officially documented presentations of overdose for this combination product are primarily related to Hypercalcaemia (excess calcium in the blood) and Hypervitaminosis D.

Regulatory labeling specifies that overdose may initially present with common signs such as anorexia, nausea, vomiting, and thirst, along with systemic symptoms like muscle weakness and confusion. Overdose can progress to severe outcomes, including irreversible renal impairment, nephrocalcinosis (calcification in the kidneys), and potentially cardiac arrhythmia.

Overdose Severity / Risk
Severe Outcomes: Irreversible renal damage, cardiac arrhythmia, coma, and death in extreme cases.
Vulnerable Populations: Patients with kidney failure and elderly patients require especially critical monitoring.

Regulatory documents explicitly mandate that individuals must seek immediate medical attention at the first sign of an adverse reaction or if an overdosage is suspected. The immediate action prescribed is the discontinuation of the product. The official supportive management described includes necessary measures to lower serum calcium levels, such as rehydration (high fluid intake) and the use of specific pharmacological treatments like bisphosphonates or corticosteroids.

Monitoring of key parameters, including serum electrolyte levels and renal function, is required during the management of an overdose situation.

Therapeutic Uses of Effercal D3

Effercal D3 is a combined supplement intended to help maintain normal levels of Vitamin D and calcium within the body. These nutrients are essential for addressing clinical scenarios related to confirmed deficiency states.

The supplement is primarily used as an aid in the management of specific categories of conditions associated with calcium deficiency and Vitamin D deficiency. This includes individuals managing conditions such as osteomalacia (softening of the bones) and certain forms of osteoporosis in adults. It may also be used in cases where dietary intake alone is determined to be insufficient to meet the body’s requirements.

The therapeutic benefit provided is the support of bone integrity and the maintenance of normal muscle function. Ensuring adequate intake of these components is a supportive measure in a comprehensive strategy for long-term skeletal health.

Quick Fact: Relief for Confirmed Deficiency States

Eligibility and Restrictions for Use

Effercal D3 is officially indicated for use in Adults and Older People to address confirmed calcium and Vitamin D deficiencies. Its eligibility is strictly governed by regulatory guidelines related to pre-existing conditions and age-based authorization.

Contraindications

The medicine is contraindicated and must not be used by patients who have high levels of calcium in the blood (Hypercalcaemia) or urine (Severe Hypercalciuria), excess Vitamin D (Hypervitaminosis D), or Nephrolithiasis (kidney stones). It is also strictly prohibited for patients with Severe Renal Impairment.

Age- and Condition-Based Restrictions

  • For Children and Adolescents, use is generally not recommended as official regulatory safety and efficacy profiles have not been established.
  • Conditional use applies to certain populations, such as those with Mild to Moderate Renal Impairment or Sarcoidosis, who may use the product but require close medical monitoring of calcium levels.
  • During Pregnancy and Lactation, the medicine is permitted only when a confirmed deficiency exists and is subject to strict maximum dose limits.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for this combination of Calcium Carbonate and Colecalciferol (Vitamin D3) documents specific pharmacokinetic and pharmacodynamic interactions.

Timing-Mandated Separation Rules

To prevent the formation of non-absorbable complexes that reduce the exposure of co-administered medicines, separation of dosing is required. Effercal D3 must be taken at least two hours before or four to six hours after oral administration of tetracycline antibiotics and quinolone antibiotics. A separation of at least three hours is mandated for bisphosphonates and sodium fluoride, and at least four hours for levothyroxine.

Pharmacodynamic and Metabolic Interactions

Co-administration with thiazide diuretics may reduce the renal excretion of calcium, leading to an officially documented increased risk of hypercalcaemia. The calcium component can potentiate the effects of cardiac glycosides, carrying an increased risk of cardiac arrhythmias should calcium levels become elevated. Substances classified as hepatic enzyme inducers, such as phenytoin and barbiturates, are documented to accelerate the metabolism of Colecalciferol, thereby reducing its effect.

Food and Supplement Interactions

The intake of food components rich in oxalic acid (e.g., spinach, rhubarb) and phytic acid (in whole cereals) is documented to inhibit calcium absorption due to the formation of insoluble compounds. Effercal D3 should not be taken within two hours of consuming these foods. Co-administration with other high-dose Vitamin D products is restricted due to the documented risk of mineral toxicity.

Mechanism of Action

The mechanism influences systemic calcium homeostasis. The elemental Calcium component provides an essential substrate for bone matrix formation and participates directly in numerous intracellular signaling cascades. The Vitamin D3 component, cholecalciferol, undergoes two-step hydroxylation to its active metabolite, calcitriol (1,25-(OH)2D3). This active form functions as a highly specific agonist at the Vitamin D Receptor (VDR).

VDR activation results in the translocation of the receptor complex to the nucleus, where it acts as a transcription factor. This binding increases the gene expression of proteins, including Calbindin D28k, which facilitates the absorption of dietary calcium across the intestinal epithelium. The resulting modulation of circulating calcium levels acts as a cofactor in numerous enzymatic reactions and modulates cellular membrane permeability, ultimately influencing the balance between osteoblast and osteoclast activity and affecting bone mineralization processes.

Dosage and Administration Information

How to Use Effercal D3: Official Administration Guidelines

Effercal D3, which combines calcium carbonate and colecalciferol (Vitamin D3), is intended for oral administration. The administration method depends on the form: the Effervescent Tablet must be fully dissolved in a glass of water and the solution consumed immediately. If using a Chewable Tablet form, the unit dose must be chewed thoroughly before swallowing.

The standard adult dosing protocol is often a divided use schedule, such as taking one unit dose in the morning and one in the evening, to supply a total daily dose typically ranging from 1000 mg to 1200 mg of elemental calcium and 800 IU or more of Vitamin D3. This frequency is established to optimize intestinal calcium absorption.

Administration Requirements and Timing

Administration is generally permitted with or without food. However, specific time-separation constraints are mandatory to prevent absorption interference. The product must be taken several hours apart from certain therapeutic agents, including some bisphosphonates and tetracycline or quinolone antibiotics. A separation time of at least two hours must also be observed when consuming foods high in oxalic or phytic acid. For long-term use, periodic monitoring of serum and urinary calcium levels, along with kidney function, is a procedural condition of the treatment protocol. The medicine is generally not recommended for children under 12 years of age at the standard adult strengths.

Recent Clinical Evidence

Effercal D3: Recent Clinical Evidence

Effercal D3, a combination of calcium and Vitamin D3 (cholecalciferol), is primarily indicated for correcting combined calcium and Vitamin D deficiencies and as an adjunct to specific osteoporosis treatment. Its clinical profile is supported by numerous studies examining the role of these essential nutrients in bone health and mineral homeostasis.


Efficacy in Fracture Prevention

Large-scale clinical trials and systematic reviews have explored the use of calcium and Vitamin D supplementation in reducing fracture risk, particularly in elderly populations. A combination therapy has been associated with a reduction in the relative risk of hip fractures when compared to placebo in some meta-analyses. However, evidence remains mixed on the effect of supplementation on non-vertebral or vertebral fractures when considering various dosages, patient populations, and baseline dietary intake.

Studies suggest the greatest benefit may be observed in individuals with insufficient baseline calcium and Vitamin D intake, highlighting that these agents are considered threshold nutrients.


Impact on Bone Mineral Density (BMD)

Research confirms the fundamental role of Vitamin D in increasing the intestinal absorption of calcium, which supports the body's calcium stores and subsequent bone remineralization. By correcting deficiencies, the combined therapy aims to counteract the increase in parathyroid hormone (PTH) levels, which can lead to increased bone resorption and loss of BMD.

Safety and Formulation

The formulation's effervescent delivery method is one of several oral options (including chewable and swallowable tablets). Studies assessing patient preference for different calcium/D3 formulations have reported varying results; while some patients may prefer one specific form, tolerability profiles for most modern formulations, including effervescent powders, are generally comparable, with common minor side effects being gastrointestinal events (e.g., constipation or bloating).

Frequently Asked Questions (FAQ)

Common questions about Effercal D3 (FAQ)

Q: Is Effercal D3 the same as taking a regular Vitamin D supplement?

No, official documentation describes Effercal D3 as a combination product containing both calcium carbonate and colecalciferol (Vitamin D3). It is typically indicated for correcting combined calcium and Vitamin D deficiencies. This combined-ingredient approach is distinct from the use of a single-ingredient Vitamin D supplement.


Q: What happens if a scheduled intake of Effercal D3 is missed?

Official patient information generally advises that if a dose is missed, patients should take it as soon as it is remembered, unless it is very close to the time of the next scheduled dose. If so, official information generally advises that patients skip the missed dose and continue with their regular schedule. Official patient information often specifies that patients should avoid taking a double dose to make up for a forgotten one.


Q: Is Effercal D3 gluten-free or suitable for people with Celiac disease?

Regulatory documents list the inactive ingredients, or excipients, for this product. Information regarding the presence of gluten or other common allergens is available in the full composition details. The official product insert contains a detailed list of these ingredients.


Q: Does Effercal D3 affect blood sugar levels?

Official regulatory safety data primarily focuses on the components' roles in calcium homeostasis, which is the body's way of managing calcium levels. Direct, clinically significant changes to blood sugar levels are generally not listed as a common side effect or a required monitoring point for the drug's primary indications.


Q: Does Effercal D3 interfere with iron supplements?

Yes, regulatory documentation states that the calcium component can reduce the absorption of certain products, including oral iron supplements, due to effects on stomach acidity. Regulatory documents typically advise a time-separation of dosing to minimize this interaction.


Q: Is Effercal D3 indicated for children or adolescents?

Official product labels typically specify the approved population. Standard adult strengths of Effercal D3 are often not recommended for children under 12 years due to specific dosing considerations. Dosing and use in adolescents are typically determined based on individual status and regulatory guidelines.


Q: How soon after starting Effercal D3 do patients usually notice a change in bone health markers?

Regulatory data indicates that the Vitamin D component undergoes a physiological process to reach its active form. While initial changes in blood levels may start earlier, the peak effect on serum levels can take approximately one month of daily dosing to achieve a steady state. Changes in major bone health markers typically require several months of consistent treatment to become measurable.


Q: What is the typical timeframe for a treatment course involving Effercal D3?

Effercal D3 is often used for conditions that require sustained nutritional support. Regulatory information indicates the product is often used for long-term periods and requires periodic monitoring of calcium levels and renal (kidney) function during treatment.


Q: What is Effercal D3 used for, according to official sources?

Official sources state that the product is indicated for the prevention and treatment of combined calcium and Vitamin D deficiencies, and it may also be used as an adjunct (or supportive) treatment alongside specific osteoporosis therapies for patients who are deficient.


Q: Can Effercal D3 be used long-term?

Regulatory documents describe the product as suitable for long-term use but require mandatory periodic monitoring of blood calcium and kidney function, particularly in elderly patients and those with existing kidney issues.


Q: Are there any common digestive side effects reported for Effercal D3?

Yes, official adverse reaction reports classify certain gastrointestinal disorders as common or expected. These may include effects such as constipation, flatulence (gas), and general gastric pain.


Q: What is the maximum amount of time before the effects of Effercal D3 start?

Regulatory data on the Vitamin D component indicate that its conversion to the active form and subsequent action is a gradual process. Significant changes in serum Vitamin D levels often reach a stable level (steady state) around one month after starting daily dosing.


Q: Is it possible for Effercal D3 to interact with multivitamins?

Yes, official labels often restrict co-administration with other high-dose Vitamin D products due to a documented risk of mineral toxicity and elevated calcium levels (hypercalcaemia). Patients can check the Vitamin D and calcium content of any multivitamin to help avoid excessive intake.


Q: Are there any restrictions on Effercal D3 use for people with pre-existing heart conditions?

Caution is noted in regulatory information for patients receiving cardiac glycosides (a type of heart medication). This is because the calcium component can potentially increase the risk of cardiac arrhythmias (irregular heart rhythms) if calcium levels in the blood become too high.


Q: Is Effercal D3 appropriate for pregnant or breastfeeding individuals?

Regulatory information describes its use as acceptable during pregnancy and lactation, provided that total intake of calcium and Vitamin D remains within established guidelines. High doses, however, may be associated with risks.


Q: What have clinical studies shown regarding the effectiveness of Effercal D3?

Clinical evidence has shown that the combination therapy promotes efficient calcium absorption. Studies have also indicated that the use of calcium and Vitamin D in combination may be associated with a decrease in the relative risk of hip fractures in some patient populations, especially those with existing deficiencies.


Q: Why is calcium combined with Vitamin D in this formulation?

The combination is based on the fundamental role of Vitamin D in the body's chemistry. Vitamin D3 is necessary to produce its active metabolite, which acts to increase the intestinal absorption of calcium. Combining the two ingredients promotes the effective absorption and utilization of calcium by the body.


Q: Do people typically need a prescription to get Effercal D3?

In many countries, this combination of calcium and Vitamin D is available over-the-counter (OTC) as a supplement for deficiency correction. Specific, higher-strength formulations or different pack sizes, however, may be classified as prescription-only medicines depending on local regulations.


Q: Are there different strengths or formulations of Effercal D3 available?

Official documents confirm that the product is available in different physical forms, such as Effervescent Tablets and Chewable Tablets. It is also marketed in various strengths, offering different amounts of elemental calcium and Vitamin D3.


Q: Is Effercal D3 known to cause headaches or dizziness?

Official adverse reaction reports have noted headache as an adverse reaction in some cases related to the components of the product, although it is not considered common. Dizziness is not typically listed as a distinct common or uncommon side effect.


Q: Is it normal to feel thirsty after taking Effercal D3?

In regulatory documentation, thirst is listed as a potential symptom associated with hypercalcaemia, which means having elevated blood calcium levels. Hypercalcaemia is an uncommon but known adverse effect of this type of medicine.


Q: Can I use Effercal D3 if I am taking medicines for thyroid function?

Yes, but co-administration with levothyroxine (a common thyroid medicine) requires specific precautions. Official labels mandate a time separation of at least four hours between taking Effercal D3 and levothyroxine to prevent reduced absorption of the thyroid medicine.


Q: Why might a doctor prescribe Effercal D3 over a single ingredient supplement?

The combination product is described in official sources as being indicated when a patient has a diagnosed combined deficiency of calcium and Vitamin D. Furthermore, it may be prescribed when clinical evidence supports the combination as a necessary adjunct therapy for the management of conditions like osteoporosis.


Q: Does Effercal D3 contain any sugar or artificial sweeteners?

As an effervescent tablet, the formulation often includes sweeteners (which may be sugars or non-caloric alternatives) to make the solution palatable. The full list of excipients (inactive ingredients), including specific sweeteners used, is detailed in the official product documents.


Q: How is the bioavailability of the calcium in Effercal D3 generally described?

Official documents describe the bioavailability of calcium in the context of Vitamin D's function. The Vitamin D3 component is included to promote the efficient calcium uptake from the gastrointestinal tract, confirming its fundamental role in promoting intestinal absorption.


Q: Is it possible for Effercal D3 to interact with laxatives?

Yes, official documentation advises caution. The long-term use of high-dose stimulant laxatives is specifically documented as potentially reducing the overall absorption of the Vitamin D and calcium components of the medicine.


Q: Is there a specific mechanism of action defined for the calcium component of Effercal D3?

Yes, the official mechanism of action states that the elemental Calcium component provides an essential substrate for bone matrix formation. It also participates directly in regulating numerous physiological functions, including cellular signaling and influencing the activity of cells responsible for bone remodeling.

How should Effercal D3 be stored and disposed of?

How to Store and Dispose of Effercal D3

The official storage and disposal guidelines for Effercal D3 (Calcium Carbonate/Colecalciferol effervescent tablets) must be followed to maintain product quality and ensure environmental safety.

Storage Requirements

Requirement Official Instruction
Temperature Store at a temperature below 25°C (77°F).
Protection Protect from moisture, heat, and light.
Container Keep the tube tightly closed and store in the original package.

The medicine must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

To dispose of unused or expired medicine, patients must not throw away medicines via wastewater or household waste. Instead, ask a pharmacist how to properly discard the product according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Effercal D3 found in:

A-Z Index: